脑部放疗，上午比下午敏感许多！% l& S* p* J) F2 _4 ^7 X1 h! d5 f5 j
' B. y7 f9 M2 |6 E0 ?4 J* H4 z# s! \+ a1 M8 a* y% {
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
! x* k) i3 E, d3 U* B( D# {0 @Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
4 |( E& z, c5 M$ E+ g/ rRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
% h. R( q, v) B eSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.1 i0 J# P2 F) I& T* U
0 N: c/ ?( |3 R4 `, [
Abstract
1 Y: ]) ^6 u6 Q' [5 u! {3 l6 [BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
, Y; X% b$ Z8 K3 }0 F3 x. t! |& G
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic." w0 _5 ?( y7 u! v+ j( v
1 ] G3 D- F V& O- j1 Z( {RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
" R4 k2 l+ x5 r4 o" T% z# `4 D/ d; D8 f5 y" N
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
( n, x2 }- ?, J7 }! m" [
2 I0 @ V0 L0 b4 o1 T/ W5 f |
- }) D- A8 @1 w3 u8 v. j( ?+ ]/ m
显身卡
